Augmentiqs Pathology
It’s a new era of smart pathology.
The microscope is still the technology of choice for pathologists. It’s fast, efficient and found on every pathologist’s desk. The Augmentiqs pathology solution enhances the existing microscope, helping pathologists work more effectively, connect remotely with colleagues and conduct ground-breaking medical research. The result is pathology that’s smarter, faster, and more cost-effective.
Augmentiqs’ first solution is real-time telepathology and augmented reality of the microscope, enabling online consultations, live collaboration between remote locations and more efficient workflow. By bridging a live, online connection between pathologists, Augmentiqs is enabling better clinical outcomes, reduced costs, and more efficient workflow.
By turning the existing microscope into a smart and connected device, Augmentiqs is ushering in a new era of Smart Pathology.
Company History
Augmentiqs was founded in 2016 by alumni of the digital pathology industry who believed current solutions were not adequately meeting the true needs of pathologists.
The original concept for Augmentiqs revolved around augmented reality of the existing microscope in order to enable pathologists to use digital toolsets without having to save an image to the computer. However, we very quickly realized that the most pressing needs for pathologists include collaboration and workflow enhancement. With a slight adjustment of focus, real time telepathology, automatic reporting and LIS integration became the key drivers of the Augmentiqs pathology system.
Today, Augmentiqs is changing the entire concept of digital pathology by enabling vital toolsets within the classic workflow. By creating a digital pathology ecosystem within the existing microscope, Augmentiqs is truly offering a fresh approach to digital pathology.
Advisory
Augmentiqs is guided by leaders in pathology, optics and early-stage technology companies.
Sujatha Ramanujan, PhD
Managing Director, Luminate
Sujatha Ramanujan is a serial entrepreneur with 25 years of experience in Clinical Devices and in Consumer Electronics. Sujatha has started, built and grown three startup businesses in cardiac surgical equipment, optical communications and nano materials.
Sujatha holds 28 issued US patents, has served on investment advisories in US, Canada, and Israel, and holds a PhD in Electrical Engineering from the University of Michigan .
Don Golini
Founder, QED Technologies
Don Golini is a successful entrepreneur with extensive experience in the development, management and commercialization of new technologies. As president and founder of QED Technologies, Don licensed a university technology and developed products that succeeded in global markets.
Don was an adjunct professor at the Simon School of Business, is on the Hajim School Dean’s Visiting Committee, and is on the executive committee for the U of R Technology Development Fund.
Stephen Fantone, PhD
Founder & President, Optikos Corporation
Stephen Fantone received his S.B. degrees in E.E. and Management from MIT, and his Ph.D. from The Institute of Optics at the University of Rochester (U of R).
Dr. Fantone is the founder and president of Optikos Corporation, an engineering and instrumentation firm specializing in medical devices, diagnostics, VR, aerospace and defense, automotive and imaging applications.
He has been awarded over 65 patents covering a broad range of optical technologies.
Ryne Raffaele
VP Research, RIT
Dr. Ryne Raffaelle is the VP for Research and Associate Provost at Rochester Institute of Technology (RIT). He is the former Director of the National Center for Photovoltaics at the National Renewable Energy Lab of the U.S. Department of Energy.
Prior to serving at NREL, he was the Academic Director for the Golisano Institute for Sustainability and Director of the NanoPower Research Laboratory at RIT. He has worked as a visiting scientist at the NASA-Glenn Research Center, NASA Kennedy Research Center, and Oak Ridge National Laboratory.
Jay Kumler
CEO, Jenoptik
Jay Kumler is President of Jenoptik Optical Systems, the US optics operations of Jenoptik AG. Prior to its acquisition by Jenoptik, Jay founded and led Coastal Optical Systems for 10 years, and previously designed optical systems for United Technologies and Bell Laboratories.
With over 28 years of optical design and engineering experience, Jay is a published author, has developed patents and speaks regularly on optical solutions.
Abraham Nyska, DVM
Visiting Professor of Pathology, TAU
Dr. Nyska has nearly 40 years’ experience in evaluation and pre-clinical risk assessment regarding safety-related toxicologic and experimental pathology.
Abraham is a member of the NIH scientific advisory board, having previously worked for 10 years as a scientist at the National Toxicology Program, followed by 8 years as an NTP Consultant.
Bob Maronpot, DVM
Former Director, NIEHS/NIH
Robert R. Maronpot, DVM, MS, MPH, DACVP, DABT, has significantly influenced the field of toxicologic pathology as a leader, manager, educator, and author.
He is internationally recognized and highly respected, having served chief of experimental pathology at the NTP, as president of the Society of Toxicologic Pathology, and as editor-in-chief of its journal, Toxicologic Pathology.
Elisha Bar-Meir
Director, Mor Imaging Group
Dr. Elisha Barmeir is a Professor of Radiology at the Bruce Rappaport Faculty of Medicine, The Technion – Israel Institute of Technology. He is the Head of the Department of Radiology at Bnai Zion Hospital, Haifa.
In addition, Dr. Barmeir is the medical director of MAR and MOR-MAR imaging groups, operating approximately 50 imaging centers throughout the Israel.
